| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.07 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.092 | 0.08 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.08 | 0.08 |